Katherine K. Matthay
Department of Pediatrics
UCSF School of Medicine
505 Parnassus Ave
Box 0106
Name/email consistency: high
- Prognostic Value of the Stage 4S Metastatic Pattern and Tumor Biology in Patients With Metastatic Neuroblastoma Diagnosed Between Birth and 18 Months of Age. Taggart, D.R., London, W.B., Schmidt, M.L., Dubois, S.G., Monclair, T.F., Nakagawara, A., De Bernardi, B., Ambros, P.F., Pearson, A.D., Cohn, S.L., Matthay, K.K. J. Clin. Oncol. (2011)
- Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force. Matthay, K.K., Shulkin, B., Ladenstein, R., Michon, J., Giammarile, F., Lewington, V., Pearson, A.D., Cohn, S.L. Br. J. Cancer (2010)
- Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study. Matthay, K.K., Reynolds, C.P., Seeger, R.C., Shimada, H., Adkins, E.S., Haas-Kogan, D., Gerbing, R.B., London, W.B., Villablanca, J.G. J. Clin. Oncol. (2009)
- Iodine-131--metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I study. Matthay, K.K., Quach, A., Huberty, J., Franc, B.L., Hawkins, R.A., Jackson, H., Groshen, S., Shusterman, S., Yanik, G., Veatch, J., Brophy, P., Villablanca, J.G., Maris, J.M. J. Clin. Oncol. (2009)
- Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma. Matthay, K.K., Yanik, G., Messina, J., Quach, A., Huberty, J., Cheng, S.C., Veatch, J., Goldsby, R., Brophy, P., Kersun, L.S., Hawkins, R.A., Maris, J.M. J. Clin. Oncol. (2007)
- Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study. Matthay, K.K., Tan, J.C., Villablanca, J.G., Yanik, G.A., Veatch, J., Franc, B., Twomey, E., Horn, B., Reynolds, C.P., Groshen, S., Seeger, R.C., Maris, J.M. J. Clin. Oncol. (2006)
- Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma. Matthay, K.K., Edeline, V., Lumbroso, J., Tanguy, M.L., Asselain, B., Zucker, J.M., Valteau-Couanet, D., Hartmann, O., Michon, J. J. Clin. Oncol. (2003)
- Central nervous system metastases in neuroblastoma: radiologic, clinical, and biologic features in 23 patients. Matthay, K.K., Brisse, H., Couanet, D., Couturier, J., Bénard, J., Mosseri, V., Edeline, V., Lumbroso, J., Valteau-Couanet, D., Michon, J. Cancer (2003)
- Secondary myelodysplastic syndrome and leukemia following 131I-metaiodobenzylguanidine therapy for relapsed neuroblastoma. Weiss, B., Vora, A., Huberty, J., Hawkins, R.A., Matthay, K.K. J. Pediatr. Hematol. Oncol. (2003)
